Vimarsana
Biggest News Aggregation in the World

Page 6 - Diagnostics Division News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Diagnostics Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Diagnostics Division Today - Breaking & Trending Today

Clinical Microbiology Instruments and Reagents Global - Vimarsana News

Clinical Microbiology Instruments and Reagents Global

Dublin, June 22, 2023 (GLOBE NEWSWIRE) -- The "Clinical Microbiology Instruments and Reagents: Global Strategic Business Report" report has been added to...

A.Menarini Diagnostics announces the release of the PRIME MDx platform - Vimarsana News

A.Menarini Diagnostics announces the release of the PRIME MDx platform

/PRNewswire/ -- A.Menarini Diagnostics S.r.l. is pleased to announce the commercial launch of its PRIME MDx platform: a sample-to-result, all-in-one,...

Menarini Industrie Farmaceutiche Riunite: A.Menarini Diagnostics announces the release of the PRIME MDx platform - Vimarsana News

Menarini Industrie Farmaceutiche Riunite: A.Menarini Diagnostics announces the release of the PRIME MDx platform

FLORENCE, Italy, May 22, 2023 /PRNewswire/ -- A.Menarini Diagnostics S.r.l. is pleased to announce the commercial launch of its PRIME MDx platform: a sample-to-result, all-in-one, fully-automated

Roche Q1 Group Sales Down 3% At CER; Confirms 2023 Outlook - Vimarsana News

Roche Q1 Group Sales Down 3% At CER; Confirms 2023 Outlook

Roche (RHHBY) said the significantly lower demand for COVID-19 tests led to a decrease in first quarter Group sales of 3% at constant exchange rates and a decline of 7% in Swiss francs.

F. Hoffmann-La Roche Ltd: Roche reports strong sales growth in base business of both divisions in the first quarter; Group sales decline due to expected drop in demand for COVID-19 tests - Vimarsana News

F. Hoffmann-La Roche Ltd: Roche reports strong sales growth in base business of both divisions in the first quarter; Group sales decline due to expected drop in demand for COVID-19 tests

Basel, 26 April 2023 As expected, significantly lower demand for COVID-19 tests leads to a decrease in Group sales (-3%1 at constant exchange rates [CER] and -7% in Swiss francs); excluding this effect